Acadia Pharmaceuticals
ACAD
ACAD
318 hedge funds and large institutions have $2.85B invested in Acadia Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 99 increasing their positions, 102 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
318
Holders Change
+24
Holders Change %
+8.16%
% of All Funds
4.32%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.04%
New
65
Increased
99
Reduced
102
Closed
38
Calls
$30.3M
Puts
$5.77M
Net Calls
+$24.6M
Net Calls Change
+$13.9M
Top Buyers
| 1 |
BlackRock
New York
|
+$143M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$60.8M |
| 3 |
State Street
Boston,
Massachusetts
|
+$41.1M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$40.1M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$24.8M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$43.5M |
| 2 |
SG Americas Securities
New York
|
-$40.9M |
| 3 |
Man Group
London,
United Kingdom
|
-$17M |
| 4 |
Millennium Management
New York
|
-$16.9M |
| 5 |
D.E. Shaw & Co
New York
|
-$14.8M |
